Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

Authors: Kayvon Modjarrad, Christine C. Roberts, Kristin T Mills, Amy R. Castellano, Kristopher Paolino, Kar Muthumani, Emma L. Reuschel, Merlin L. Robb, Trina Racine, Myoung‐don Oh, Claude Lamarre, Faraz I. Zaidi, Jean Boyer, Sagar B. Kudchodkar, Moonsup Jeong, Janice M. Darden, Young K. Park, Paul T. Scott, Celine Remigio, Ajay Parikh, Megan C. Wise, Ami Patel, Elizabeth K. Duperret, Kevin Y. Kim, Hyeree Choi, S. M. White, Mark L. Bagarazzi, Jeanine May, Deborah Kane, Hyojin Lee, Gary Kobinger, Nelson L. Michael, David B. Weiner, Stephen J. Thomas, Joel N. Maslow - The Lancet 2019 cited by 322